Clinical Trials Logo
  1. Home
  2. Adverse Event
  3. NCT06230341

Patient Safety Incidents in Coordinated Primary Care Teams: a Multi-method Study — EVIDENS-Prim  

Adverse Event Clinical Trial

Official title:
Patient Safety Incidents in Coordinated Primary Care Teams: a Multi-method Study

Clinical Trial Summary

In France, improving the practice of health professionals working in coordinated primary care teams (health centres called Maisons de Santé Pluriprofessionnelles - MSPs) could be facilitated by a learning system consisting of (i) a risk management support programme and (ii) the provision of a comprehensive online system combining training, reporting and support for the analysis and management of patient safety incidents (PSIs). EVIDENS-Prim is a multi-method, multi-centre, prospective study. It aims to describe the PSIs that occur in MSPs, using an international classification system, and to describe the ways in which professionals have adopted a global approach to PSIs management, from PSI reporting to feedback.

Clinical Trial Description

This method combines: - (i) A sequential study of PSIs analysis. The sequential study will take place in three stages (coder training, collection of PSIs data via the web platform, PSIs coding). Each PSIs reported by professionals during the implementation of the risk management support programme will be coded using the PISA multi-axial classification system (based on the WHO's International Classification for Patient Safety in Primary Care). These codes will be used to describe PSIs in coordinated practice. - (ii) An implementation study of the learning system. The learning system is described in the intervention section. During the implementation study, two types of data collection (quantitative and qualitative) will be mobilised at the end of the support to the QualiREL Santé Regional Support Structure. The main objective of the study is: - To Describe PSIs occurring in MSPs as part of the coordinated exercise and over an 18-month period, according to the 4 coding frameworks of the PISA classification: (i) types of events (main and contributing), (ii) contributing factors, (iii) outcomes of PSIs, (iv) severity of harm. The secondary objectives, linked to the evaluation of the implementation of the learning system, are - To examine the acceptance of the learning system by the teams, - To describe the effective use of the web platform by professionals, - To describe the MSP's ownership of the risk management support programme. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06230341
Study type Interventional
Source Nantes University Hospital
Contact Jean-Baptiste Amélineau, MD
Phone 02 40 41 28 28
Email jean-baptiste.amelineau@univ-nantes.fr
Status Not yet recruiting
Phase N/A
Start date April 1, 2024
Completion date August 1, 2026
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03668639 - Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin Phase 2/Phase 3
Completed NCT05232656 - PREventing Adverse Events Post-Discharge Through Proactive Identification, Multidisciplinary Communication, and Technology N/A
Completed NCT03482232 - Consequences of Doing What Should Not be Done in Primary Care
Completed NCT05693051 - Use of Prone Position Ventilation in Danish Patients With COVID-19 Induced Severe ARDS Treated With VV-ECMO
Completed NCT04055363 - Human Milk Oligosaccharides (HMOs) Post-market Study on Infants N/A
Completed NCT05133817 - Prophylactic Norepinephrine Infusion Combined With Colloid Coloading for Postspinal Anesthesia Hypotension N/A
Completed NCT02996201 - Electronic Patient Reporting of Side Effects to Chemotherapy: A Cluster Randomized Controlled Trial N/A
Recruiting NCT05462938 - Conscious Sedation for Transcatheter Aortic Valve Implantation N/A
Completed NCT04562922 - LIFEMEL Efficacy in Preventing Haematopoietic Toxicity in Patients Treated With Chemotherapy Phase 2
Recruiting NCT03740464 - Long-acting G-CSF for Febrile Neutropenia Phase 3
Completed NCT03332433 - High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Gastroscopy Sedated by Propofol N/A
Not yet recruiting NCT04615156 - 18F-2-fluoro-2-deoxy-D-glucose in Positron Emission Tomography Computed Tomography Phase 3
Recruiting NCT03381534 - Safety and Efficacy of Distal Embolic Protection Device in Vertebral Artery Origin Stenting N/A
Completed NCT04570488 - Predicting Favorable Outcomes in Hospitalized Covid-19 Patients
Recruiting NCT05369962 - Adverse Event Prediction in Geriatric Patients in the ED With Ultrasound
Completed NCT05321160 - Comparison of the Sedation Effect of Esketamine and Sevoflurane for Pediatric Ophthalmological Procedure N/A
Withdrawn NCT03673566 - Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - CHMCO N/A
Completed NCT03745677 - Redesigning Systems to Improve Quality for Hospitalized Patients N/A
Completed NCT04763876 - Intramuscular Ketorolac at Two Single-Dose Regimens Phase 4
Withdrawn NCT03673579 - Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - MHSB N/A